SCHEDULE: FMR LLC, Abigail Johnson Report 0.7% Stake in Evolent Health

FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, disclosing a beneficial ownership of 0.7% of Evolent Health Inc.'s Class A Common Stock as of December 31, 2025.

Summary

• FMR LLC and Abigail P. Johnson filed an Amendment No. 2 to Schedule 13G concerning their beneficial ownership in Evolent Health Inc.
• The filing reports an aggregate beneficial ownership of 750,886.96 shares of Evolent Health Inc.'s Class A Common Stock.
• This ownership represents 0.7% of the total outstanding Class A Common Stock.
• The reported ownership stake is as of December 31, 2025.
• FMR LLC holds sole voting power over 741,735.20 shares and sole dispositive power over 750,886.96 shares.
• Abigail P. Johnson holds sole dispositive power over 750,886.96 shares, with no sole or shared voting power directly attributed.
• FMR LLC is classified as a parent holding company, and Abigail P. Johnson is an individual reporting person.
• Subsidiaries of FMR LLC, including Fidelity Diversifying Solutions LLC, Fidelity Management & Research Company LLC, and Strategic Advisers LLC, are identified as investment advisers beneficially owning shares.
• The Johnson family, including Abigail P. Johnson, are the predominant owners of FMR LLC's Series B voting common shares, representing 49% of the voting power, and are considered a controlling group with respect to FMR LLC.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it is a routine disclosure of beneficial ownership by a large institutional investor and does not indicate any significant change in strategy, performance, or outlook for Evolent Health Inc.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that institutional ownership filings like this Schedule 13G provide transparency into significant holdings by major investment firms. FMR LLC, as the parent company of Fidelity, is a prominent asset manager, and its continued, albeit small, stake in Evolent Health Inc. suggests ongoing, routine portfolio management rather than a strategic shift or activist position. This type of filing is standard for institutional investors maintaining positions below the 5% threshold for more active reporting.

Comparison to Industry Standards

• StockSavvy.ai observes that a 0.7% stake is a relatively minor position for a large institutional investor like FMR LLC in a publicly traded company.
• While it indicates a presence, it does not suggest a significant conviction or controlling interest compared to major activist stakes or foundational institutional holdings often seen in companies like BlackRock or Vanguard's passive index funds, which can hold 5-10% or more in thousands of companies.
• This is a routine disclosure for a diversified investment manager and does not imply a strategic or influential position in Evolent Health Inc.

Stakeholder Impact

• This filing primarily impacts shareholders by providing transparency regarding the beneficial ownership structure of Evolent Health Inc.'s Class A Common Stock by FMR LLC and Abigail P. Johnson.
• Given the small percentage (0.7%), the direct impact on share price or corporate strategy is likely minimal, indicating a routine investment rather than a strategic move.

Key Dates

Recommendation

This Schedule 13G filing is a routine disclosure of a relatively small, non-controlling stake by a major institutional investor. It provides no new information regarding Evolent Health Inc.'s operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. Investors should 'hold' and look to other filings for fundamental analysis.

Keywords

Evolent Health Inc, EVH, FMR LLC, Abigail P. Johnson, Schedule 13G, beneficial ownership, Class A Common Stock, institutional ownership, investment adviser, SEC filing